Arrowhead Pharmaceuticals, Inc.
- Stock
- Ticker ARWR
- ISIN US04280A1007
- Nasdaq
Performance, volatility and drawdowns of Arrowhead Pharmaceuticals, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $95,103. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −89.0% in 04/2025, measured from the peak in 02/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 2.5 | 543 | 28 | 256 | 264 | 74 | 75 | 38 |
| Operating income | -161 | 381 | -166 | 44 | 41 | -141 | -170 | -437 |
| EBITDA | -157 | 387 | -160 | 50 | 47 | -135 | -164 | -430 |
| Net income | -173 | 370 | -175 | -24 | 31 | -133 | -194 | -428 |
| Earnings per share | -1.39 | 2.75 | -1.26 | -0.18 | 0.22 | -0.93 | -1.36 | -3.01 |
| Balance sheet | ||||||||
| Total assets | 1,014 | 1,573 | 1,381 | 1,385 | 1,604 | 2,268 | 2,112 | 1,738 |
| Liabilities | 958 | 889 | 861 | 882 | 1,041 | 1,669 | 1,646 | 1,688 |
| Equity | 53 | 683 | 522 | 466 | 568 | 614 | 466 | 50 |
| Cash | 54 | 186 | 130 | 227 | 202 | 189 | 55 | 63 |
| Cash flow | ||||||||
| Operating cash flow | -146 | 460 | -155 | 20 | 13 | 84 | -177 | -192 |
| Capital expenditure | -7.5 | -5.3 | -2.4 | -7.5 | -2.1 | -2.6 | -3.9 | -3.4 |
| Free cash flow | -154 | 455 | -157 | 13 | 11 | 82 | -181 | -196 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2019 at +410.7%, weakest 2022 at −38.8%. 5 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 12 Nov 2026 | −$3.01 |
| 4 Aug 2026 | −$1.36 |
| 7 May 2026 | −$0.93 |
| 5 Feb 2026 | $0.22 |
| 25 Nov 2025 | −$0.18 |
| 7 Aug 2025 | −$1.26 |
| 12 May 2025 | $2.75 |
| 10 Feb 2025 | −$1.39 |
| 26 Nov 2024 | −$1.37 |
| 8 Aug 2024 | −$1.38 |
| 9 May 2024 | −$1.02 |
| 6 Feb 2024 | −$1.24 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €5.3bn
- Market cap in trading currency
- $5.85bn
- Enterprise value
- $4.66bn
- P/E
- –
- P/S
- 12.97
- P/B
- 116.24
- EV/Sales
- 10.33
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -4.9%
Results (last four quarters)
- Revenue
- $451m
- Gross profit
- –
- EBITDA
- −$682m
- Net income
- −$724m
- Earnings per share
- −$5.11
- Revenue per share
- $3.19
- Revenue growth
- −85.3%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- -156.9%
- Net margin
- -160.6%
- Return on equity
- -280.5%
- Return on assets
- -41.7%
Balance sheet and cash flow
- Cash
- $1.19bn
- Cash per share
- $8.44
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 4.14
- Book value per share
- $0.36
- Operating cash flow
- −$272m
- Free cash flow
- −$284m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 141m
- Volume
- 3.91m
- Avg. volume 3 months
- 1.95m
- Relative volume
- 1.9
Price and technicals
- Price
- $41.37
- 1 day
- −5.2%
- 52-week high
- $89.59
- 52-week low
- $38.09
- Distance to 52-week high
- −53.8%
- Distance to 52-week low
- +8.6%
- Distance to 50-day line
- −30.2%
- Distance to 200-day line
- −41.3%
- RSI (14)
- 21
- Volatility 1M
- 72.3%
Performance
- 1 week
- −13.4%
- 1 month
- −29.1%
- 3 months
- −52.3%
- 6 months
- −44.8%
- YTD
- −37.7%
- 1 year
- +6.2%
Dates
- Fiscal year end
- 30 Sep 2026
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ARWR performed since 11/2016?
$10,000 grew to $95,103 by 20 Nov 2026, which is +25.3% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ARWR?
Volatility was 76.2% per year, measured on monthly returns. The largest decline from a peak was −89.0%, with the low in 04/2025.
How does ARWR compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ARWR returned +25.3% at 76.2%. The correlation of monthly returns was 0.29; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.